Key result
Melatonin improves mitochondrial structure and function through multiple pathways, offering a potential therapeutic strategy against myocardial ischemia-reperfusion injury.
Why the study?
Myocardial ischemia-reperfusion injury is a major complication of reperfusion therapy for coronary heart disease, but effective intervention strategies are currently lacking.
Does melatonin ameliorate myocardial ischemia-reperfusion injury through mitochondrial quality control?
Does melatonin ameliorate myocardial ischemia-reperfusion injury through mitochondrial quality control?
Melatonin may ameliorate myocardial ischemia-reperfusion injury by improving mitochondrial structure and function through mitochondrial quality control pathways.
Hypothesis-generating for mitochondrial protection; prospective trials needed before clinical consideration in ischemia-reperfusion injury.
Melatonin exhibits various biological functions, including regulation of circadian and endocrine rhythms, anti-inflammatory, and antioxidant effects. Aging and damaged mitochondria are major sources of oxidative stress (OS), and mitochondrial quality control (MQC) is crucial for maintaining normal mitochondrial function. Myocardial ischemia-reperfusion injury is a major complication that can arise during reperfusion therapy for coronary heart disease. However, effective intervention strategies are currently lacking. Mitochondrial dysfunction and OS are considered central mechanisms of myocardial reperfusion injury, with mitochondrial-targeted interventions being a potential treatment direction. Recent studies have shown that melatonin improves mitochondrial structure and function through multiple pathways. This review discusses the mechanisms by which melatonin ameliorates myocardial ischemia-reperfusion injury, focusing on MQC, and explores its potential applications in the prevention and treatment of myocardial ischemia-reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Ghavamikia et al. (2025) conducted a review in Myocardial ischemia-reperfusion injury. Melatonin was evaluated. Melatonin improves mitochondrial structure and function through multiple pathways, offering a potential therapeutic strategy against myocardial ischemia-reperfusion injury.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: